Delivery Order SPE2DB24D2101-SPE2DB25FKPBU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. This non-set-aside award, issued on August 21, 2025, carries a ceiling value of $9,966.92 and is scheduled for completion by August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $4,833.56. The award was made on June 26, 2025, with an ultimate completion date of June 27, 2025, and represents a competitively awarded, non-set-aside procurement. Performance of this delivery order will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,923.39 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,759.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and utilizes no set-aside designation, indicating open competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,896.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award with an ultimate completion date of August 27, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $25,599.93, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,282.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement with no set-aside designation, indicating the award was competitively available. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,316.89 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 4, 2025, with ultimate completion by August 5, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPBUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price arrangement. The contract, valued at $17,575.02, was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a competitive award with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp maintains extensive federal contracting relationships supporting military and veteran healthcare systems. The company's contract portfolio encompasses a broad range of pharmaceutical products and medical supplies delivered through firm fixed-price delivery orders to support Defense Health Agency requirements and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 9/2/25 |